From soaring drug expenses in the Great Plains to rising supply costs in the West, regional disparities highlight the unique pressures facing hospital leaders. As labor shortages persist, supply ...

It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

Professor Timothy Yang, associate professor and director of the Center for Asian Studies at the University of Georgia, ...

In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

Tarsus Pharmaceuticals is making a splash with Xdemvy, an eye drop that kills the demodex mites that cause inflammation and ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Royalty Pharma (RPRX – Research Report), ...

The Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 1.25% and 1.32%, respectively, in Q3 ...

The Indian Healthcare industry continued its healthy growth in 2023 and reached ... under the US$ 169.2 million National Technical Textiles Mission. 10 Feb 25 India's pharmaceutical exports set for ...